Announcements Trials
Browse Landscape

Phase

Phase 2 34Phase 3 5Phase 1/2 4Phase 2/3 3Phase 1 2Phase NA 1Phase 4 1

Status

Completed 64Terminated 22Recruiting 20Active not recruiting 16Unknown 6Withdrawn 3Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasm Metastasis 2Neoplasms 1

Interventions

Cyclophosphamide 22fludarabine 17Specimen Handling 13Magnetic Resonance Spectroscopy 10pembrolizumab 9Nivolumab 9Radiotherapy 7Cisplatin 7fludarabine phosphate 5Injections 5Doxorubicin 5Biopsy 5tislelizumab 4daratumumab 4Rituximab 4Paclitaxel 4Ipilimumab 4Interleukin-2 4Immune Checkpoint Inhibitors 4Gemcitabine 4Fluorouracil 4Drug Therapy 4Dexamethasone 4Carboplatin 4venetoclax 3toripalimab 3ruxolitinib 3X-Rays 3Vincristine 3Radiosurgery 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × 130-nm albumin-bound paclitaxel × Clear all
NCT07454031 2026-03-13

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

Peking University

Phase 1 Not yet recruiting
22 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT07348107 2026-01-16

ATARI-PDAC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Not yet recruiting
10 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡